Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Grifols says due diligence done, Shanghai RAAS stake sale to go ahead

Published 01/03/2024, 08:19
Updated 01/03/2024, 08:20
© Reuters. FILE PHOTO: The logo of the Spanish pharmaceuticals company Grifols is pictured on theirs facilities in Parets del Valles, north of Barcelona, Spain, January 9, 2024. REUTERS/Albert Gea/File Photo
GRLS
-
GRFS
-

MADRID (Reuters) - Grifols' $1.8 billion sale of a 20% stake in Shanghai RAAS will proceed after a due diligence process concluded "satisfactorily", the Spanish drug maker said on Friday.

Grifols said the sale to Haier Smart Home, announced in late December, will be completed by the end of the first half of this year provided all the regulatory hurdles are cleared.

Grifols, which produces drugs made with blood plasma, had said it would use the proceeds to reduce its debt.

The company has lost about half its market valuation since early January when short-seller Gotham City Research issued a report questioning its accounting and its debt levels. Grifols has dismissed the report, insisting its data is correct, and has sued Gotham City.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.